The story of Viagra, initially marketed by copyright, presents a fascinating case study for investors considering the pharmaceutical landscape . Although its early success and impact of vast in sales, the exclusivity lapse has opened the way for competing medications, significantly eroding income potential . This transition raises doubts about the